Key Performance
More- Earnings Score: 45
- Momentum Score: 25
- True Yield: N/A
- Financial Health Score: 47
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
A class action lawsuit has been filed against Chemours Company alleging that executives failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
11/10/2026, 11:00 AM • GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC has filed class action lawsuits against Lululemon Athletica, Chemours Company, and O-I Glass for alleged securities fraud. Lululemon is accused of failing to disclose deteriorating store traffic and demand due to negative media commentary and weak product launches, while misrepresenting its financial guidance and turnaround plans. Investors in these companies during specified periods are encouraged to seek recovery.
11/10/2026, 11:00 AM • GlobeNewswire
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
11/06/2026, 11:00 AM • GlobeNewswire
Chemours faces a securities class action lawsuit for failing to disclose material information about refrigerant aftermarket demand during February-August 2026. The company cut full-year EBITDA guidance and admitted to channel oversupply, resulting in an 18.63% stock price decline on August 5, 2026. Investors have until December 7, 2026 to file lead plaintiff applications.
11/03/2026, 10:38 PM • GlobeNewswire
A class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly overstating market demand for its Opteon products and providing unreliable financial guidance. The company reduced its full-year adjusted EBITDA guidance in August 2026, causing the stock to drop 18.63%. Investors who purchased CC securities between February 20, 2026 and August 4, 2026 may be eligible to participate in the lawsuit.
10/30/2026, 12:16 AM • GlobeNewswire
The Chemours Company faces a securities class action lawsuit for failing to disclose material information between February and August 2026. The company cut its full-year adjusted EBITDA guidance significantly after revealing channel oversupply issues, causing its stock to fall 18.63% on August 5, 2026. Investors with losses exceeding $100,000 have until December 7, 2026 to file lead plaintiff applications.
10/29/2026, 6:27 PM • GlobeNewswire
Kahn Swick & Foti, LLC announces a securities class action lawsuit against The Chemours Company for allegedly failing to disclose material information about refrigerant aftermarket demand during February 20 - August 4, 2026. The company cut full-year adjusted EBITDA guidance and revealed that executives misrepresented channel inventory levels, resulting in an 18.63% stock price decline on August 5, 2026. Investors have until December 7, 2026 to file lead plaintiff applications.
10/27/2026, 9:35 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against The Chemours Company for allegedly making materially false statements about financial guidance during February-August 2026. The company overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price drop of 18.63% on August 5, 2026, after the company reduced its full-year EBITDA guidance and reported a 4% volume decline.
10/25/2026, 7:13 PM • GlobeNewswire
A class action lawsuit has been filed against Chemours Company alleging that the company failed to disclose material information about overstated aftermarket demand for Opteon products and decreasing demand, resulting in unreliable financial guidance for 2026. Investors who purchased Chemours securities between February 20, 2026 and August 4, 2026 are encouraged to join the case, with a lead plaintiff deadline of December 7, 2026.
10/23/2026, 11:00 AM • GlobeNewswire
The Chemours Company faces a securities class action lawsuit for failing to disclose material information during February-August 2026. The company cut its full-year adjusted EBITDA guidance significantly after revealing channel oversupply issues, causing its stock to plunge 18.63% on August 5, 2026. Investors with losses exceeding $100,000 have until December 7, 2026 to file lead plaintiff applications.
10/22/2026, 2:58 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. Chemours stock fell 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance and attributed the decline to a 4% decrease in volumes, primarily from lower Opteon refrigerant aftermarket sales. The deadline to seek lead plaintiff status is December 7, 2026.
10/20/2026, 6:10 PM • GlobeNewswire
A securities fraud class action has been filed against The Chemours Company (NYSE: CC) for allegedly overstating market demand for its Opteon products during the Class Period (February 20 - August 4, 2026). The company reduced its full-year EBITDA guidance and disclosed an oversupplied channel, causing the stock to drop 18.63% on August 5, 2026. The lead plaintiff deadline is December 7, 2026.
10/15/2026, 8:40 PM • GlobeNewswire
A securities fraud class action lawsuit has been filed against The Chemours Company (NYSE: CC) for allegedly making materially false statements about the reliability of its financial guidance. The lawsuit covers investors who purchased CC securities between February 20, 2026 and August 4, 2026. The company allegedly overstated aftermarket demand for its Opteon refrigeration products, leading to a significant stock price decline of 18.63% on August 5, 2026, after the company reduced its full-year adjusted EBITDA guidance.
10/15/2026, 5:45 PM • GlobeNewswire
ClaimsFiler reminds investors with losses exceeding $100,000 that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company. The lawsuit alleges that Chemours and its executives failed to disclose material information about channel oversupply during the Class Period (February 20 - August 4, 2026). The company cut its full-year adjusted EBITDA guidance significantly, causing its stock to fall 18.63% on August 5, 2026.
10/15/2026, 2:43 PM • GlobeNewswire
The global high-performance fluoropolymers market is projected to grow from USD 5.17 billion in 2026 to USD 7.82 billion by 2032 at a CAGR of 7.11%, driven by semiconductor fabrication, electric vehicle electrification, battery technology, and hydrogen infrastructure demands. Key growth factors include regulatory compliance requirements, AI-driven innovation in materials discovery, and expanding applications across aerospace, medical devices, and industrial coatings.
08/27/2026, 6:56 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 11/12/2026
Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.